![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.
21 months median OS in amezalpat arm vs. 15 in control arm 50% (20/40) of patients on amezalpat arm remain in survival follow up 0.65 hazard ratio, maintained since 0.59 observed in primary...
BRISBANE, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...
BRISBANE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated...
BRISBANE, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.05 | -2.32558139535 | 2.15 | 2.185 | 2.01 | 505052 | 2.12511754 | CS |
4 | -1.06 | -33.5443037975 | 3.16 | 3.24 | 1.87 | 2519865 | 2.09626799 | CS |
12 | -1.72 | -45.0261780105 | 3.82 | 3.86 | 1.87 | 1005017 | 2.40109822 | CS |
26 | -1.98 | -48.5294117647 | 4.08 | 6 | 1.87 | 1006600 | 3.48162355 | CS |
52 | 0.7 | 50 | 1.4 | 9.77 | 0.17 | 3330429 | 5.66344089 | CS |
156 | -9.38 | -81.7073170732 | 11.48 | 41 | 0.17 | 1220877 | 6.16883073 | CS |
260 | -11.71 | -84.7936278059 | 13.81 | 41 | 0.17 | 1213732 | 6.17311183 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions